Type 2 & other diabetes

Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality

J Clin Endocrinol MetabPublished Model development and validation study with cohort analysis

Authors' conclusion

We propose a new model of IS in patients with T2D based on readily available clinical and laboratory data. Its potential applications are in both diagnosis as well as prognostication.

Study context

Population
Patients with T2D: 140 with euglycemic hyperinsulinemic clamp; 3553 from National Health and Nutrition Examination Survey (NHANES) 1999–2010clamp cohort
Participants
140 patients
Outcome
Model of insulin sensitivity from clinical and laboratory parameters vs clamp-derived glucose disposal rate; association with all-cause and cardiovascular mortality
Methodological detailseuglycemic hyperinsulinemic clamp, stepwise linear regression, training and validation cohorts, multivariable Cox proportional hazard model
  • Euglycemic hyperinsulinemic clamp
  • Stepwise linear regression
  • Training and validation cohorts
  • Multivariable Cox proportional hazard model

Performance

As reported in the abstract

IS score correlation with clamp-derived glucose disposal rate
Test or modelValueP
Trainingr 0.77P < .001
Validationr 0.74P < .001

Value

Trainingr 0.77
Validationr 0.74

P

TrainingP < .001
ValidationP < .001

Further findings

All-cause and cardiovascular mortality, NHANES cohort · median follow-up 8.3 years

Deaths
1054
Cardiovascular deaths
265
Higher estimated insulin sensitivity (IS) associated with lower risk of all-cause and cardiovascular mortality
  • Multivariable Cox model adjusted for age, sex, race-ethnicity, education, smoking, total cholesterol, CKD, blood pressure, prevalent CVD and alcohol consumption

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality. J Clin Endocrinol Metab. Published 22 November 2023. doi:10.1210/clinem/dgad682

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.